In the global pharmaceutical supply chain, identifying reliable manufacturers for critical intermediates is a strategic imperative. For companies involved in the production of Escitalopram, a widely used antidepressant, securing a consistent supply of high-quality precursors is essential. The compound identified by CAS number 128173-53-5, known as (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt, is a vital intermediate in this process.

As a prominent manufacturer and supplier based in China, we specialize in providing this specific pharmaceutical intermediate. Buyers actively search for terms such as 'Escitalopram precursor China manufacturer' or 'buy CAS 128173-53-5' to connect with reliable sources. Our expertise lies in delivering this compound with the required purity and consistency, ensuring it meets the demanding standards of the pharmaceutical industry. We understand the importance of competitive pricing and a stable supply chain, making us an ideal partner for your procurement needs.

The synthesis of Escitalopram relies heavily on the quality of its precursors. Therefore, sourcing from a reputable manufacturer that offers 'high purity Escitalopram intermediate manufacturer' services is crucial. Our commitment extends beyond just supplying the chemical; we focus on building lasting relationships with our clients by ensuring product integrity and efficient delivery. For pharmaceutical companies looking to optimize their production costs, inquiring about 'pharmaceutical intermediate price' is a standard practice, and we are well-positioned to offer attractive terms.

Whether your needs are for research and development or large-scale commercial production, our capabilities in 'custom synthesis 128173-53-5' and our established manufacturing processes ensure we can meet diverse requirements. By partnering with us, you gain access to a reliable supply of this essential pharmaceutical intermediate, directly from a dedicated China manufacturer. This ensures a streamlined procurement process, better cost control, and ultimately, a more efficient route to market for your pharmaceutical products.